Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nemonoxacin vs Moxifloxacin in Adult CAP
NCT01944774Phase 2Completed
- Sponsor
- TaiGen Biotechnology Co., Ltd.
- Start
- Mar 2013
- Primary completion
- Dec 2013
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of nemonoxacin in community acquired pneumonia (CAP), sponsored by TaiGen Biotechnology Co., Ltd.. Started Mar 2013; status: completed.
02
Drugs
nemonoxacin
03
Conditions
community acquired pneumonia (CAP)
Beyond the preview
Go deeper on NCT01944774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01944774.